Characterization of Dynamic Stability in Normal Pressure Hydrocephalus and Parkinson's Disease
HPGAIT
1 other identifier
observational
150
1 country
1
Brief Summary
This study aims to characterize dynamic stability disorders in two conditions mainly affecting the elderly and with similar walking deficits: hydrocephalus at normal pressure and Parkinson's disease, to provide the most relevant monitoring criteria in usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 7, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedAugust 21, 2023
August 1, 2023
4 months
August 7, 2023
August 16, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Coefficient of variation in step length
Coefficient of variation in step length during 8-meter comfortable walking test
30 seconds
Study Arms (2)
Normal pressure hydrocephalus
Patients with a diagnosis of normal pressure hydrocephalus and who performed a gait analysis in laboratories
Parkinson's disease
Patients with a diagnosis of Parkinson's disease and who performed a gait analysis in laboratories
Interventions
The subject is asked to walk 8 meters 3 times: at free speed, at fast speed, and with large steps.
Eligibility Criteria
Patients with normal pressure hydrocephalus or Parkinson's disease.
You may qualify if:
- Age \>18 years
- Patient who performed a walking test in the Laboratory Analysis and Restoration of Movement
- Diagnosis of normal pressure hydrocephalus or Parkinson's disease
You may not qualify if:
- Levodopa drugs administrated during a delay of 12 hours before walking test
- Presence of an other neurologic disease or of any disease associated with motor disorders in lower limb.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratoire Analyse et Restauration du Mouvement
Créteil, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emilie Hutin
Henri Mondor University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-director of laboratory
Study Record Dates
First Submitted
August 7, 2023
First Posted
August 21, 2023
Study Start
June 1, 2023
Primary Completion
September 30, 2023
Study Completion
December 31, 2023
Last Updated
August 21, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share